Literature DB >> 17151118

The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner.

Subhash C Verma1, Tathagata Choudhuri, Erle S Robertson.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) persists as episomes in infected cells by circularizing at the terminal repeats (TRs). The KSHV episome carries multiple reiterated copies of the terminal repeat, and each copy is capable of supporting replication. Expression of the latency-associated nuclear antigen (LANA) is critical for the replication of TR-containing plasmids. A 32-bp sequence upstream of LANA binding site 1 (LBS1), referred to as RE (replication element), along with LANA binding sites 1 and 2 (RE-LBS1/2), is sufficient to support replication (J. Hu and R. Renne, J. Virol. 79:2637-2642, 2005). In this report we demonstrate that the minimal replicator element (RE-LBS1/2) replicates in synchrony with the host cellular DNA, and only once, in a cell-cycle-dependent manner. Overexpression of the mammalian replication inhibitor geminin blocked replication of the plasmid containing the minimal replicator element, confirming the involvement of the host cellular replication control mechanism, and prevented rereplication of the plasmid in the same cell cycle. Overexpression of Cdt1 also rescued the replicative ability of the RE-LBS1/2-containing plasmids. A chromatin immunoprecipitation assay performed using anti-origin recognition complex 2 (alpha-ORC2) and alpha-LANA antibodies from cells transfected with RE-LBS1/2, RE-LBS1, LBS1, or RE showed the association of ORC2 with the RE region. Expression of LANA increased the number of copies of chromatin-bound DNA of replication elements, suggesting that LANA is important for the recruitment of ORCs and may contribute to the stabilization of the replication protein complexes at the RE site.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151118      PMCID: PMC1866078          DOI: 10.1128/JVI.01607-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  p53 inhibition by the LANA protein of KSHV protects against cell death.

Authors:  J Friborg; W Kong; M O Hottiger; G J Nabel
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

2.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

3.  The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.

Authors:  M A Cotter; E S Robertson
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

4.  Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus.

Authors:  A Schepers; M Ritzi; K Bousset; E Kremmer; J L Yates; J Harwood; J F Diffley; W Hammerschmidt
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

5.  Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells.

Authors:  K A Staskus; W Zhong; K Gebhard; B Herndier; H Wang; R Renne; J Beneke; J Pudney; D J Anderson; D Ganem; A T Haase
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes.

Authors:  S J Gao; Y J Zhang; J H Deng; C S Rabkin; O Flore; H B Jenson
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

7.  Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

Authors:  E T Lennette; D J Blackbourn; J A Levy
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

Review 8.  Control of DNA replication licensing in a cell cycle.

Authors:  Hideo Nishitani; Zoi Lygerou
Journal:  Genes Cells       Date:  2002-06       Impact factor: 1.891

9.  The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA.

Authors:  Andrew J Barbera; Jayanth V Chodaparambil; Brenna Kelley-Clarke; Vladimir Joukov; Johannes C Walter; Karolin Luger; Kenneth M Kaye
Journal:  Science       Date:  2006-02-10       Impact factor: 47.728

10.  Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1.

Authors:  S C Hung; M S Kang; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  23 in total

1.  Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin.

Authors:  Jie Lu; Masanao Murakami; Subhash C Verma; Qiliang Cai; Sabyasachi Haldar; Rajeev Kaul; Mariusz A Wasik; Jaap Middeldorp; Erle S Robertson
Journal:  Virology       Date:  2010-11-19       Impact factor: 3.616

Review 2.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

3.  Monitoring plasmid replication in live mammalian cells over multiple generations by fluorescence microscopy.

Authors:  Kathryn Norby; Ya-Fang Chiu; Bill Sugden
Journal:  J Vis Exp       Date:  2012-12-13       Impact factor: 1.355

4.  Analysis of DNA methylation in human BK virus.

Authors:  Chi-Fang Chang; Meilin Wang; Chiung-Yao Fang; Pei-Lain Chen; Shu-Fen Wu; Michael W Y Chan; Deching Chang
Journal:  Virus Genes       Date:  2011-05-31       Impact factor: 2.332

5.  Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats.

Authors:  Pravinkumar Purushothaman; Maria E McDowell; James McGuinness; Ruth Salas; Sharif M Rumjahn; Subhash C Verma
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

6.  Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhiheng He; Yunhua Liu; Deguang Liang; Zhuo Wang; Erle S Robertson; Ke Lan
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

7.  Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Jianhong Hu; Eugene Liu; Rolf Renne
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation.

Authors:  Huaxin Si; Subhash C Verma; Michael A Lampson; Qiliang Cai; Erle S Robertson
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

9.  Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance.

Authors:  Rebecca L Skalsky; Jianhong Hu; Rolf Renne
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

10.  Identification of properties of the Kaposi's sarcoma-associated herpesvirus latent origin of replication that are essential for the efficient establishment and maintenance of intact plasmids.

Authors:  Prabha Shrestha; Bill Sugden
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.